Invention Grant
US08518932B2 Oxime azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
失效
肟基氮杂环丁烷衍生物作为鞘氨醇-1-磷酸（S1P）受体调节剂
- Patent Title: Oxime azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
- Patent Title (中): 肟基氮杂环丁烷衍生物作为鞘氨醇-1-磷酸（S1P）受体调节剂
-
Application No.: US13300873Application Date: 2011-11-21
-
Publication No.: US08518932B2Publication Date: 2013-08-27
- Inventor: Wenkui K. Fang , Liming Wang , Evelyn G. Corpuz , Ken Chow , Wha-Bin Im
- Applicant: Wenkui K. Fang , Liming Wang , Evelyn G. Corpuz , Ken Chow , Wha-Bin Im
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Doina G. Ene
- Main IPC: C07D205/04
- IPC: C07D205/04 ; A61K31/397
Abstract:
The present invention relates to novel oxime azetidine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
Public/Granted literature
- US20120142661A1 NOVEL OXIME AZETIDINE DERIVATIVES AS SPHINGOSINE 1-PHOSPHATE (S1P) RECEPTOR MODULATORS Public/Granted day:2012-06-07
Information query
